 |
|
 |
February 21, 2008 |
Now Available:
Download the podcast of Dr. Gaylis's video presentation
CME Opportunity:
International Society of Extremity MRI in Rheumatology Conference:
Chicago, April 10, 2008
Musculoskeletal Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.
With biweekly and special edition newsletters, MSK Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.
Consumer News: Learn what your patients are reading in the popular press
Women More Likely to Postpone New Knees
Women are waiting longer to undergo knee replacement surgery than men, and the delay may cause greater disability...
New from PubMed: Keep up-to-date with what is on PubMed
Computer-Assisted Validation of the Synovitis Score
Researchers assessed the reliability of the synovitis score as a grading system for chronic joint diseases...
MSK Video Report:
Adopting Imaging in RA Management and Rheumatology Practice
Dr. Norman Gaylis discusses the role of imaging in diagnosing and treating RA...
Arthritis:
Glucosamine Misses GOAL in Hip OA Study
The first major trial of glucosamine sulfate in early hip OA found that it was no better than placebo at reducing pain, improving function, or slowing progression...
Arthritis:
Stress Triggers TNFα Production in RA Patients—Unless They Are Taking a TNF Inhibitor
Psychological stress triggers monocyte TNFα production in RA patients, and TNFα inhibitors protect against this stress response, which may cause the disease flares often reported by patients after stressful experiences...
AAPM 2008:
Studies of OA, Back Pain Drugs Reported at AAPM Meeting
Extended-release analgesics get top billing at AAPM meeting...
BioPharm Business:
Pfizer Gains Worldwide Exclusive License From Scil Technology for CD-RAP, a Novel Cartilage Growth Factor, in OA
Pfizer Inc and Scil Technology GmbH have signed a worldwide license agreement for Scil Technology's cartilage specific growth factor CD-RAP (cartilage-derived retinoic-acid-sensitive protein)...
BioPharm Business:
Pharmacopeia Advances Chemokine Receptor Antagonist Into Preclinical Development for Inflammatory and Autoimmune Disease Indications
Pharmacopeia Inc announced the advancement of PS031291, a potent and highly selective oral antagonist at the chemokine receptor CCR1, as a preclinical development compound from its internal CCR1 discovery program...